ASO Author Reflections: Is There an Extra Benefit of Adding Neoadjuvant Radiotherapy to Chemotherapy in Patients with (Borderline) Resectable Pancreatic Cancer?
Saved in:
| Title: | ASO Author Reflections: Is There an Extra Benefit of Adding Neoadjuvant Radiotherapy to Chemotherapy in Patients with (Borderline) Resectable Pancreatic Cancer? |
|---|---|
| Authors: | Yun WG; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Jang JY; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. jangjy4@snu.ac.kr. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2025 Apr; Vol. 32 (4), pp. 2859-2860. Date of Electronic Publication: 2025 Jan 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1534-4681 |
|---|---|
| DOI: | 10.1245/s10434-024-16829-x |
